Page 58 - Livre électronique du congrès national de pneumologie 2023
P. 58

40 male patients, with confirmed COPD and in stable
              condition. This group was  matched to the patient   P71          ASSESSING
              group. Patients  with COPD-associated respiratory   OXYHEMOGLOBIN IN CHRONIC
              disease and receiving immunosuppressive treatment   OBSTRUCTIVE PULMONARY DISEASE
              were excluded. Patients were interviewed  and      PATIENTS ADMITTED FOR SEVERE
              examined. The severity of the disease was assessed
              using the ABCD assessment tool of the Global Initiative   COMMUNITY-ACQUIRED
              for Chronic Obstructive Lung  Disease 2022 (GOLD).   PNEUMONIA
              Blood samples including prostaglandins (D2, E2, F2alpha
              and 6-keto-prostaglandin  1 alpha), C-reactive protein   W.  JELASSI,  S.  TOUJANI,  K.  EUCHI,  N.H.  KHEZAMI,  N.
              (CRP) levels as well as a forced airway measurement   HAMMOUDA,  S.  CHEIKHROUHOU,  Y.  OUAHCHI,  M.  MJID,
              were performed.                                       HEDHLI. A, B. DHAHRI
                                                                    PNEUMOLOGY DEPARTMENT, LA RABTA HOSPITAL, LR18SP02, TUNIS
              Results :                                             FACULTY OF MEDICINE, TUNIS EL MANAR UNIVERSITY, TUNIS, TUNISIA

              The mean age was 64 ±8 years in patients versus 59±7   Introduction :
              years in controls. COPD was classified as stage 3 in 17%   Various variables, such as the Body Mass Index (BMI)
              of cases and stage 4 in 17% of cases. The distribution of   and the degree of  airflow obstruction have been
              patients according to the ABCD assessment tool was :   shown to be a predictive metric in chronic obstructive
              GOLD A in 5%, GOLD B in 55%, GOLD C in 20% and GOLD   pulmonary disease (COPD). The use of blood gas
              D in 20%. The analysis of prostaglandins showed a   analyses has been largely restricted to the acute
              significantly higher levels of PGD2 (p< 10-3), PGE2 (p< 10-  exacerbations of the disease.  Recent  studies have
              3), PGF2a (p< 10-3) and 6-Keto-prostalgandin 1-alpha (6-K-  demonstrated  that  oxygenated  hemoglobin
              PG-1a) in the COPD group. PGE2 had the highest     (OxyHem) is a useful prognostic predictor in acute
              significant diagnostic value on the ROC curve analysis   exacerbations of COPD.
              (AUC=0,826, P< 10-3). The risk  of COPD  was 13 times
              higher for PGD2, 31 times higher for PGE2, about 3 times   The objective of our study was to assess the predictive
              higher for PGF2a, and 7 times higher for 6-Keto-PG1a.   prognostic value of OxyHem in patients admitted for
                                                                 severe community acquired pneumonia (CAP) in this
              PGF2a,  PGD2 and CRP plasma levels had a negative   category of patients.
              correlation with peripheral oxygen saturation (r=-0,360,
              p=0,023; r=-0,333, p=0,036; and r=-0,568, P<10-3   Methods
              respectively).
                                                                 We conducted a cross-sectional study in a cohort of
              The analysis of these biomarkers according to groups   consenting patients followed for confirmed COPD with
              and stages of COPD showed a significantly negative   a history of hospitalisation for CAP at a pulmonology
              correlation between PGD2 and Forced  expiratory    Department, from  January 2022 until August 2023.
              volume in one second (FEV1) (r=-0,374, p=0,017).   Disease severity was assessed using spirometry,  the
                                                                 improved  ABCD assessment tool according to the
              No correlation was found between prostaglandins and   latest Global Initiative on Obstructive Lung Disease
              the number or severity of acute exacerbations of COPD.    (GOLD) 2023 recommendations, and the  modified
              Conclusions:                                       Medical Research Council (mMRC) dyspnea scale. We
                                                                 calculated OxyHem (hemoglobin concentration [Hb] ×
              This study offers useful and critical data that contribute   fractional SpO2, g/dL) from oxygen saturation
              to a better understanding of  the etiopathogenic   measured  by pulse oximetry  and hemoglobin
              mechanisms involved in COPD.                       assessed at admission. Patients were divided in two
                                                                 groups: Group 1 (G1) represented patients who either

                                                                 were transferred to the intensive care unit (ICU) or who
                                                                 died ; Group 2 (G2) : patients who were not transferred
                                                                 to the ICU.

                                                                 Results

                                                                 We included 104 patients. The mean age was  0.63±11.14
                                                                 years with a sex ratio of 4.2. Active smoking was noted
                                                                 in 63 (60.57%) patients. Overall,  59 (56.7%)  were
                                                                 transferred to the ICU and 11 patients (10.5%) died. Non-




                                                                                                     Page 53
   53   54   55   56   57   58   59   60   61   62   63